Press release from Companies: Inhalation Sciences presents comprehensive new strategy update

Press release from Companies: Inhalation Sciences AB secures long-term financing of operations

Press release from Companies: Inhalation Sciences AB säkerställer långsiktig finansiering av verksamheten

Market Notices: Market Notice 86/22– Last day of trading in Inhalation Sciences Sweden AB’s subscription option ISAB TO 1

Press release from Companies: Inhalation Sciences AB: Subscription price determined for warrants of series TO 1 where the subscription period begins on May 23, 2022.

Press release from Companies: Inhalation Sciences AB: Teckningskurs fastställd för teckningsoptioner av serie TO 1 där teckningsperiod inleds den 23 maj 2022.

Press release from Companies: Inhalation Sciences AB (publ) releases Q1 Report 2022

Press release from Companies: Inhalation Sciences AB (publ) publicerar delårsrapport för det första kvartalet 2022

Press release from Companies: Kommuniké från årsstämma i Inhalation Sciences Sweden AB (publ)

Press release from Companies: Inhalation Sciences receives positive feedback from FDA, moves onto next stage of process to validate DissolvIt as FDA-recommended standard research method in US

Press release from Companies: Inhalation Sciences AB signs new distribution agreement to cover China, Hong Kong and Macau

Press release from Companies: Inhalation Sciences AB signs new distribution agreement with leading UK Labtech supplier